This 1 Innovation Could Make These 2 Biotechs Soar by 2030

This 1 Innovation Could Make These 2 Biotechs Soar by 2030

Source: 
Motley Fool
snippet: 
  • It's cumbersome and costly to manufacture complicated cell therapies.
  • Caribou Biosciences and CRISPR Therapeutics have a better way of doing things.
  • But both need to validate their approach in further clinical trials.